A 68-year-old woman with stage 3b chronic kidney disease (eGFR 32 mL/min/1.73 m²) and long-standing hypertension has persistent proteinuria (uACR 25 mg/mmol) despite maximal RAAS blockade. According to CKD management guidance, which additional intervention best slows CKD progression and reduces cardiovascular risk?